Search Results
CMS Announces New Standards for Medicaid DUR Programs to Combat Opioid Misuse and Abuse
New Medicaid Drug Utilization Review standards build on existing state activities to encourage appropriate use of opioids and other medications.
Press releaseCMS Announces New Support for Babies, Pregnant Women, and Mothers Affected by Substance and Opioid Use Disorders
Guidance announced today explains additional options to help to combat the opioid crisis.
Press releaseCMS Approves Louisiana State Plan Amendment for Supplemental Rebate Agreements Using a Modified Subscription Model for Hepatitis C Therapies in Medicaid
Today the Centers for Medicare and Medicaid Services (CMS) approved Louisiana’s Medicaid State Plan Amendment (SPA) authorizing the state to negotiate supplemental rebate agreements from prescription drug manufacturers.
Press releaseCMS Commits $50 Million to Assist States with Substance Use Disorder Treatment and Recovery
Today, the Centers for Medicare & Medicaid Services (CMS) announced a Notice of Funding Opportunity (insert link) that provides State Medicaid agencies with information to apply for planning grants that will aid in the treatment and recovery of substance use disorders (SUDs), including opioid use disorder (OUD).
Press releaseCMS Issues Renewed Guidance in Effort to Ensure Medicaid Program Integrity, Signifies Agency’s Commitment to Safeguard Health and Welfare of Medicaid enrollees
Today, the Centers for Medicare & Medicaid Services (CMS) issued guidance to state Medicaid agencies that outlines the necessary assurances that states should make to ensure that program resources are reserved for those who meet eligibility requirements.
Press releaseCMS Approves Washington State Plan Amendment Proposal to Allow Supplemental Rebates involving a “Subscription” Model for Prescription Drug Payment in Medicaid
Today, the Centers for Medicare & Medicaid Services (CMS) approved the fourth Medicaid state plan amendment proposal to negotiate supplemental rebate agreements involving value-based purchasing arrangements with drug manufacturers that allows states to link payment for prescription drugs to the value delivered.
Press releaseCMS Issues New Guidance Addressing Spread Pricing in Medicaid, Ensures Pharmacy Benefit Managers are not Up-Charging Taxpayers
Agency issues guidance for Medicaid Managed Care and CHIP health plans that clarifies how current regulations require “spread pricing” to be accounted in the calculation of Medical Loss Ratios (MLRs)
Press release